The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Open accessAbstract
Objective: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE. Methods: The classification criteria were derived from a set of 702 expert‐rated patient scenarios. Recursive partitioning was used to derive an initial rule that was simplified and refined based on SLICC physician consensus. The SLICC group validated the classification criteria in a new validation sample of 690 new expert‐rated patient scenarios. Results: Seventeen criteria were identified. In the derivation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (49 versus 70; P = 0.0082) and had greater sensitivity (94% versus 86%; P < 0.0001) and equal specificity (92% versus 93%; P = 0.39). In the validation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (62 versus 74; P = 0.24) and had greater sensitivity (97% versus 83%; P < 0.0001) but lower specificity (84% versus 96%; P < 0.0001). Conclusion: The new SLICC classification criteria performed well in a large set of patient scenarios rated by experts. According to the SLICC rule for the classification of SLE, the patient must satisfy at least 4 criteria, including at least one clinical criterion and one immunologic criterion OR the patient must have biopsy‐proven lupus nephritis in the presence of antinuclear antibodies or anti–double‐stranded DNA antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Systemic Lupus International Collaborating Clinics (SLICC) criteria published in 2012 showed that, although highly specific, the sensitivity of the ACR classification criteria for SLE was suboptimal, especially in new-onset SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, anti-dsDNA testing is an essential part of the diagnosis, classification, and management of SLE (2,3,(11)(12)(13)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These criteria proposed to classify only patients that have at least one immunologic criterion, overcoming SLE classification based solely on clinical manifestations.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients without the listed autoantibodies or low complement cannot be classified as having SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“new classification criteria for SLE were issued in 2012 by the Systemic Lupus International Collaborating Clinics (SLICC)”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The new SLICC classification criteria contain several novelties compared to the ACR criteria [18].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The existence of anti-dsDNA Abs in the absence of positive ANA results is thought to be a rare phenomenon that is attributed to laboratory errors [40].”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“SLE patients were diagnosed according to revised ACR and SLICC criteria [23, 24].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“Since 2012, the IgA isotype of the aPL has been accepted as a laboratory criterion for SLE in the SLICC SLE Classification Criteria [23].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“The included studies used ACR 1982 (33), ACR 1997 (13), SLICC 2012 (3), or a combination of these classification criteria to define the SLE group.”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,867
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H. K., Deyo, R. A., Gabriel, S. E., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,599
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Gladman, D. D., Ginzler, E. M., Goldsmith, C. H., Fortin, P. R., Liang, M. H., Sánchez‐Guerrero, J., Urowitz, M. B., Bacon, P., Bombardieri, S., Hanly, J. G., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,589
Self-citationNavarra, S., Guzmán, R., Gallacher, A., Hall, S., Levy, R. A., Jimenez, R., Li, E. K., Thomas, M., Kim, H., Leon, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,078
Self-citationEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S. E., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,054
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Weening, J. J., ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T. H., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00443.x · Cited by 1,649
Self-citation
Cited by
Sorted by citations
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40930 · Cited by 2,677
Self-citationAringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214819 · Cited by 1,612
Self-citationKaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz‐Irastorza, G., & Hughes, G. R. V. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,480
Self-citationHuman autoimmune diseases: a comprehensive update
Wang, L., Wang, F., & Gershwin, M. E. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12395 · Cited by 1,274
Anders, H., Saxena, R., Zhao, M., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 1,032
Kiriakidou, M., & Ching, C. L. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202006020 · Cited by 854
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 818
Self-citationUpdate οn the diagnosis and management of systemic lupus erythematosus
Fanouriakis, A., Tziolos, N., Bertsias, G. K., & Boumpas, D. T. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218272 · Cited by 776
Lisnevskaia, L., Murphy, G., & Isenberg, D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60128-8 · Cited by 752
Self-citationGlobal epidemiology of systemic lupus erythematosus
Barber, M. R. W., Drenkard, C., Falasinnu, T., Hoi, A. Y.-B., Mak, A., Kow, N. Y., Svenungsson, E., Peterson, J., Clarke, A. E., & Ramsey‐Goldman, R. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00668-1 · Cited by 763
Self-citationManagement strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O’Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 654
Self-citationFurer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Meidan, R., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220647 · Cited by 654
Novel paradigms in systemic lupus erythematosus
Dörner, T., & Furie, R. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30546-x · Cited by 573
Wallace, D. J., Furie, R. A., Tanaka, Y., KALUNIAN, K. C., Mosca, M., Petri, M., Dörner, T., Cardiel, M. H., Bruce, I. N., Gomez, E. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31363-1 · Cited by 518
Self-citationEarly-stage symptomatic osteoarthritis of the knee — time for action
Mahmoudian, A., Lohmander, S. L., Mobasheri, A., Englund, M., & Luyten, F. P. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00673-4 · Cited by 469
Somers, E. C., Marder, W., Cagnoli, P. C., Lewis, E. E., DeGuire, P., Gordon, C., Helmick, C. G., Wang, L., Wing, J. J., Dhar, J. P., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38238 · Cited by 446
Self-citationDamoiseaux, J., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantonio, P. L. C., Fritzler, M. J., Garcia de la Torre, I., Herold, M., Klotz, W., Cruvinel, W. D. M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214436 · Cited by 378
Gordon, C., Amissah-Arthur, M.-B., Gayed, M., Brown, S., Bruce, I. N., D’Cruz, D. P., Empson, B., Griffiths, B., Jayne, D. R. W., Khamashta, M. A., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex286 · Cited by 371
Self-citationThe Incidence and Prevalence of Systemic Lupus Erythematosus, 2002–2004: The Georgia Lupus Registry
Lim, S. S., Bayakly, A. R., Helmick, C. G., Gordon, C., Easley, K. A., & Drenkard, C. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38239 · Cited by 358
Self-citationAbsher, D., Li, X., Waite, L. L., Gibson, A., Roberts, K., Edberg, J. C., Chatham, W. W., & Kimberly, R. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003678 · Cited by 352
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Perl, A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 348
Kiriakidou, M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-7-201310010-01004 · Cited by 333
van Vollenhoven, R., Hahn, B. H., Tsokos, G. C., Wagner, C. L., Lipsky, P. E., Touma, Z., Werth, V. P., Gordon, R. M., Zhou, B., Hsu, B. L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32167-6 · Cited by 329
Self-citationCutaneous lupus erythematosus: Diagnosis and treatment
Okon, L., & Werth, V. P. (2013) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2013.07.008 · Cited by 318
Self-citationDiagnostic criteria for systemic lupus erythematosus: A critical review
Yu, C., Gershwin, M. E., & Chang, C. C.-C. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.004 · Cited by 318
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 315
The Role of Epigenetics in Autoimmune/Inflammatory Disease
Surace, A. E. A., & Hedrich, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01525 · Cited by 316
End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1
Freedman, B. I., Langefeld, C. D., Andringa, K. K., Croker, J. A., Williams, A. H., Garner, N. E., Birmingham, D. J., Hebert, L. A., Hicks, P. J., Segal, M. S., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38220 · Cited by 302
Self-citationHaematological manifestations of lupus
Fayyaz, A., Igoe, A., Kurien, B. T., Danda, D., James, J. A., Stafford, H. A., & Scofield, R. H. (2015) · Lupus Science & Medicine · doi:10.1136/lupus-2014-000078 · Cited by 304
Clinical aspects of autoimmune rheumatic diseases
Goldblatt, F., & O'Neill, S. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61499-3 · Cited by 297
Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
Cinquanta, L., Fontana, D. E., & Bizzaro, N. (2017) · Autoimmunity Highlights · doi:10.1007/s13317-017-0097-2 · Cited by 295
Macedo, A. C. L., & Isaac, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00055 · Cited by 293
Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Duvvuri, B., & Lood, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00502 · Cited by 282
Morand, E. F., Pike, M. C., Merrill, J. T., van Vollenhoven, R., Werth, V. P., Hobar, C., Delev, N. G., Shah, V., Sharkey, B., Wegman, T., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42391 · Cited by 280
Self-citationDifferences in disease phenotype and severity in SLE across age groups
Ambrose, N., Morgan, T. A., Galloway, J. B., Ionnoau, Y., Beresford, M. W., & Isenberg, D. A. (2016) · Lupus · doi:10.1177/0961203316644333 · Cited by 277
Self-citationEpidemiology of systemic lupus erythematosus
Pons‐Estel, G., Ugarte-Gil, M. F., & Alarcón, G. S. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1327352 · Cited by 271
Self-citationVučković, F., Krištić, J., Gudelj, I., Teruel, M., Keser, T., Pezer, M., Pučić‐Baković, M., Štambuk, J., Trbojević‐Akmačić, I., Barrios, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39273 · Cited by 270
Anti-DNA antibodies–quintessential biomarkers of SLE
Pisetsky, D. S. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.151 · Cited by 267
Dai, X., Fan, Y., & Zhao, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02168-0 · Cited by 280
The classification and diagnosis of cutaneous lupus erythematosus
Kuhn, A., & Landmann, A. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.021 · Cited by 256
Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus
He, Z., Shao, T., Li, H., Xie, Z., & Wen, C. (2016) · Gut Pathogens · doi:10.1186/s13099-016-0146-9 · Cited by 261
Lupus nephritis: clinical presentations and outcomes in the 21st century
Gasparotto, M., Gatto, M., Binda, V., Doria, A., & Moroni, G. L. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa381 · Cited by 257
Maggi, P., Absinta, M., Grammatico, M., Vuolo, L., Emmi, G., Carlucci, G., Spagni, G., Barilaro, A., Repice, A. M., Emmi, L., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25146 · Cited by 249
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
Kioon, M. D. A., Tripodo, C., Fernández, D., Kirou, K. A., Spiera, R., Crow, M. K., Gordon, J., & Barrat, F. J. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8458 · Cited by 258
The Diagnosis and Treatment of Systemic Lupus Erythematosus
Kuhn, A., Bonsmann, G., Anders, H., Herzer, P., Tenbrock, K., & Schneider, M. (2015) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2015.0423 · Cited by 255
Fortuna, G., & Brennan, M. T. (2013) · Dental Clinics of North America · doi:10.1016/j.cden.2013.06.003 · Cited by 234
Xist ribonucleoproteins promote female sex-biased autoimmunity
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., Li, R., Yu, B., Srinivasan, S., Abe, B. T., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.037 · Cited by 233
Self-citationChaturvedi, S., Braunstein, E. M., Yuan, X., Yu, J. M., Alexander, A. A., Chen, H., Gavriilaki, E., Alluri, R. K., Streiff, M. B., Petri, M., et al. (2019) · Blood · doi:10.1182/blood.2019003863 · Cited by 232
Self-citationIzmirly, P., Kim, M., FRIEDMAN, D. M., Costedoat-Chalumeau, N., Clancy, R. M., Copel, J. A., Phoon, C. K. L., Cuneo, B. F., Cohen, R. E., Robins, K. R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.045 · Cited by 231
Self-citationClinical and Immunological Biomarkers for Systemic Lupus Erythematosus
Yu, H., Nagafuchi, Y., & Fujio, K. (2021) · Biomolecules · doi:10.3390/biom11070928 · Cited by 228
Inflammatory markers in systemic lupus erythematosus
Aringer, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102374 · Cited by 229
Neuropsychiatric lupus: a mosaic of clinical presentations
Kivity, S., Agmon‐Levin, N., Zandman‐Goddard, G., Chapman, J., & Shoenfeld, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0269-8 · Cited by 219
Perl, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12756 · Cited by 218
Atisha‐Fregoso, Y., Malkiel, S., Harris, K. M., Byron, M., Ding, L., Kanaparthi, S., Barry, W. T., Gao, W., Ryker, K., Tosta, P., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41466 · Cited by 218
Self-citationCholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity
Westerterp, M., Gautier, E. L., Ganda, A., Molusky, M. M., Wang, W., Fotakis, P., Wang, N., Randolph, G. J., D'Agati, V. D., Yvan-Charvet, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.005 · Cited by 218
Immunometabolism in systemic lupus erythematosus
Morel, L. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.43 · Cited by 219
Groot, N., de Graeff, N., Avčin, T., Bader‐Meunier, B., Brogan, P. A., Doležalová, P., Feldman, B. M., Koné‐Paut, I., Lahdenne, P., Marks, S. D., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210960 · Cited by 216
van der Meulen, T. A., Harmsen, H. J. M., Vila, A. V., Kurilshikov, A., Liefers, S. C., Zhernakova, A., Fu, J., Wijmenga, C., Weersma, R. K., de Leeuw, K., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.009 · Cited by 218
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Ünlü, O., Zuily, S., & Erkan, D. (2015) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2015.0085 · Cited by 212
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus
Govoni, M., Bortoluzzi, A., J, M. P. J., Silvagni, E., Borrelli, M., Donelli, F., Ceruti, S., & Trotta, F. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.013 · Cited by 208
Autoantibodies in SLE: Specificities, Isotypes and Receptors
Dema, B., & Charles, N. (2016) · Antibodies · doi:10.3390/antib5010002 · Cited by 220
Maggi, P., Sati, P., Nair, G., Cortese, I. C. M., Jacobson, S., Smith, B., Nath, A., Ohayon, J. M., Pesch, V. V., Perrotta, G., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25877 · Cited by 216
Mähler, M., Meroni, P. L., Bossuyt, X., & Fritzler, M. J. (2014) · Journal of Immunology Research · doi:10.1155/2014/315179 · Cited by 212
Systemic lupus erythematosus and ocular involvement: an overview
Dammacco, R. (2017) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0479-9 · Cited by 206
Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus
Li, Y., Wang, H., Li, X., Li, H., Zhang, Q., Zhou, H., He, Y., Li, P., Chen, F., Zhang, X.-H., et al. (2019) · Clinical Science · doi:10.1042/cs20180841 · Cited by 206
Smith, E. M. D., Lythgoe, H., Midgley, A., Beresford, M. W., & Hedrich, C. M. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108274 · Cited by 206
Systemic Lupus Erythematosus in Children and Young People
Charras, A., Smith, E. M. D., & Hedrich, C. M. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00985-0 · Cited by 211
Ribeiro, A. C. D. M., Aikawa, N. E., Saad, C. G. S., Yuki, E. F. N., Pedrosa, T. D. N., Fusco, S. R. G., Rojo, P. T., Pereira, R. M. R., Shinjo, S. K., Andrade, D. C. O., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01469-5 · Cited by 197
Souyris, M., Mejía, J. E., Chaumeil, J., & Guéry, J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0712-y · Cited by 202
Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
Didier, K., Bolko, L., Giusti, D., Toquet, S., Robbins, A., Antonicelli, F. D., & Servettaz, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00541 · Cited by 199
Leuchten, N., Hoyer, A., Brinks, R., Schoels, M., Schneider, M., Smolen, J., Johnson, S. R., Daikh, D., Dörner, T., Aringer, M., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23292 · Cited by 190
Rovin, B. H., Caster, D. J., Cattran, D. C., Gibson, K. L., Hogan, J. J., Moeller, M. J., Roccatello, D., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.008 · Cited by 190
The complement system and human autoimmune diseases
Coss, S. L., Zhou, D., Chua, G. T., Abdul‐Aziz, R., Hoffman, R. P., Wu, Y. L., Ardoin, S. P., Atkinson, J. P., & Yu, C. Y. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102979 · Cited by 189
Extrahepatic autoimmune conditions associated with primary biliary cirrhosis
Floreani, A., Franceschet, I., Cazzagon, N., Spinazzè, A., Buja, A., Furlan, P., Baldo, V., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8427-x · Cited by 188
Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis
Gomez Mendez, L. M., Cascino, M. D., Garg, J., Katsumoto, T. R., Brakeman, P., Dall’Era, M., Looney, R. J., Rovin, B., Dragone, L., & Brunetta, P. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01070118 · Cited by 188
Gaforio, J. J., Visioli, F., Alarcón-de-la-Lastra, C., Castañer, O., Delgado-Rodríguez, M., Fitó, M., Hernández, A. F., Huertas, J. R., Martínez-González, M. A., Menendez, J. A., et al. (2019) · Nutrients · doi:10.3390/nu11092039 · Cited by 187
Cozzani, E., Drosera, M., Gasparini, G., & Parodi, A. (2014) · Autoimmune Diseases · doi:10.1155/2014/321359 · Cited by 187
Effect of pregnancy on disease flares in patients with systemic lupus erythematosus
Eudy, A. M., Siega‐Riz, A. M., Engel, S. M., Franceschini, N., Howard, A. G., Clowse, M. E. B., & Petri, M. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212535 · Cited by 186
Self-citationJesús, D., Matos, A. C., Henriques, C., Zen, M., Larosa, M., Iaccarino, L., da Silva, J. A. P., Doria, A., & Inês, L. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214502 · Cited by 186
Izmirly, P., Wan, I., Sahl, S., Buyon, J. P., Belmont, M. H., Salmon, J. E., Askanase, A., Bathon, J. M., Geraldino-Pardilla, L. B., Ali, Y., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40192 · Cited by 182
Self-citationEULAR/ACR classification criteria for SLE
Aringer, M. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.09.009 · Cited by 184
Petri, M., & Magder, L. S. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40571 · Cited by 175
Self-citationGuideline for the investigation and management of eosinophilia
Butt, N. M., Lambert, J., Ali, S., Beer, P. A., Cross, N. C. P., Duncombe, A. S., Ewing, J. C., Harrison, C. N., Knapper, S., McLornan, D. P., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14488 · Cited by 173
Golder, V., Kandane‐Rathnayake, R., Huq, M. M., Nim, H. T., Louthrenoo, W., Luo, S., Wu, Y. J., Lateef, A., Sockalingam, S., Navarra, S., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30037-2 · Cited by 166
The diagnosis and classification of undifferentiated connective tissue diseases
Mosca, M., Tani, C., Vagnani, S., Carli, L., & Bombardieri, S. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.019 · Cited by 165
Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis
Rijnink, E. C., Teng, Y. K. O., Wilhelmus, S., Almekinders, M. M., Wolterbeek, R., Cransberg, K., Bruijn, J. A., & Bajema, I. M. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10601016 · Cited by 165
Cabral-Marques, O., Marques, A. H. C., Giil, L. M., Vito, R. D., Rademacher, J., Günther, J., Lange, T., Humrich, J. Y., Klapa, S., Schinke, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07598-9 · Cited by 168
The diagnosis and management of the haematologic manifestations of lupus
Velo-García, A., Castro, S. G., & Isenberg, D. A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.07.001 · Cited by 165
Self-citationJarukitsopa, S., Hoganson, D. D., Crowson, C. S., Sokumbi, O., Davis, M. D. P., Michet, C. J., Matteson, E. L., Kremers, H. M., & CHOWDHARY, V. R. (2014) · Arthritis Care & Research · doi:10.1002/acr.22502 · Cited by 158
Update on differences between childhood-onset and adult-onset systemic lupus erythematosus
Mina, R., & Brunner, H. I. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4256 · Cited by 158
Inês, L., da Silva, J. A. P., Galindo-Izquierdo, M., López-Longo, F. J., Terroso, G., Romão, V. C., Rúa‐Figueroa, Í., Santos, M. J., Pego‐Reigosa, J. M., Nero, P., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22539 · Cited by 155
Giornale italiano di Dermatologia e Venereologia
Ribero, S., Quaglino, P., Sanlorenzo, M., Osella‐Abate, S., Marenco, F., Fierro, M. T., & Bernengo, M. G. (2012) · Institutional Research Information System University of Turin (University of Turin) · Cited by 155
Damoiseaux, J. G. M. C., von Mühlen, C. A., Torre, I. G.-D. L., Carballo, O. G., Cruvinel, W. D. M., Francescantônio, P. L. C., Fritzler, M. J., Herold, M., Mimori, T., Satoh, M., et al. (2016) · Autoimmunity Highlights · doi:10.1007/s13317-016-0075-0 · Cited by 154
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus
da Trindade, V. C., Carneiro-Sampaio, M. M. S., Bonfá, E., & Silva, C. A. (2021) · Pediatric Drugs · doi:10.1007/s40272-021-00457-z · Cited by 158
Unmet medical needs in systemic lupus erythematosus
Lateef, A., & Petri, M. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3919 · Cited by 152
Self-citationO’Dwyer, T., Durcan, L., & Wilson, F. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.04.003 · Cited by 151
Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease
Yang, P., Zhong, Y., Du, L., Chi, W., Chen, L., Zhang, R., Zhang, M., Wang, H., Hong, L., Yang, L., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.2664 · Cited by 150
Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus
Gergianaki, I., Bortoluzzi, A., & Bertsias, G. K. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.09.004 · Cited by 149
B cell alterations during BAFF inhibition with belimumab in SLE
Ramsköld, D., Parodis, I., Lakshmikanth, T., Sippl, N., Khademi, M., Chen, Y., Zickert, A., Mikeš, J., Achour, A., Amara, K., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.035 · Cited by 148
Mixed connective tissue disease
Gunnarsson, R., Hetlevik, S. O., Lilleby, V., & Molberg, Ø. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.03.002 · Cited by 147
Metadata
- Authors
- Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., Sturfelt, G., Ramsey‐Goldman, R., Bae, S., Hanly, J. G., Sánchez‐Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., Gladman, D., Kalunian, K., Costner, M., Werth, V. P., Zoma, A., Bernatsky, S., Ruiz‐Irastorza, G., Khamashta, M. A., Jacobsen, S., Buyon, J. P., Maddison, P., Dooley, M. A., van Vollenhoven, R. F., Ginzler, E., Stoll, T., Peschken, C., Jorizzo, J. L., Callen, J. P., Lim, S. S., Fessler, B. J., Inanc, M., Kamen, D. L., Rahman, A., Steinsson, K., Franks, A. G., Sigler, L., Hameed, S., Fang, H., Pham, N., Brey, R., Weisman, M. H., McGwin, G., & Magder, L. S.
- Affiliations
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Birmingham (GB)
- Oklahoma Medical Research Foundation (US)
- Centre hospitalier universitaire de Québec (CA)
- Manchester Academic Health Science Centre (GB)
- Cedars-Sinai Medical Center (US)
- Skåne University Hospital (SE)
- Northwestern University (US)
- Dalhousie University (CA)
- Mount Sinai Hospital (CA)
- Feinstein Institute for Medical Research (US)
- Toronto Western Hospital (CA)
- University of California San Diego (US)
- University of Pennsylvania (US)
- Hairmyres Hospital (GB)
- McGill University Health Centre (CA)
- University of the Basque Country (ES)
- St Thomas' Hospital (GB)
- New York University (US)
- Ysbyty Gwynedd Hospital NHS Trust (GB)
- University of North Carolina at Chapel Hill (US)
- Karolinska University Hospital (SE)
- SUNY Downstate Health Sciences University (US)
- Spitäler Schaffhausen (CH)
- Atrium Health Wake Forest Baptist (US)
- University of Louisville (US)
- Emory University (US)
- Medical University of South Carolina (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Petri, Michelle
- ORCID
- Petri, Michelle
- Orbai, Ana‐Maria
- Alarcón, Graciela S.
- Gordon, Caroline
- Merrill, Joan T.
- Fortin, Paul R.
- Bruce, Ian N.
- Isenberg, David
- Wallace, Daniel J.
- Nived, Ola
- Ramsey‐Goldman, Rosalind
- Bae, Sang‐Cheol
- Hanly, John G.
- Sánchez‐Guerrero, Jorge
- Clarke, Ann
- Aranow, Cynthia
- Manzi, Susan
- Urowitz, Murray
- Gladman, Dafna
- Kalunian, Kenneth
- Werth, Victoria P.
- Bernatsky, Sasha
- Ruiz‐Irastorza, Guillermo
- Khamashta, Munther A.
- Buyon, Jill P.
- Maddison, Peter
- Ginzler, Ellen
- Stoll, Thomas
- Peschken, Christine
- Jorizzo, Joseph L.
- Callen, Jeffrey P.
- Lim, S. Sam
- Kamen, Diane L.
- Rahman, Anisur
- Franks, Andrew G.
- Fang, Hong
- Brey, Robin
- Weisman, Michael H.
- McGwin, Gerald
- Magder, Laurence S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-07-27
- Volume
- 64
- Issue
- 8
- Pages
- 2677-2686
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC3409311
- OpenAlex
- W2159860161
- Cited by
- 5,322
- References
- 38
- Citations by year
- 2026: 322 · 2025: 421 · 2024: 454 · 2023: 507 · 2022: 550 · 2021: 572 · 2020: 524 · 2019: 450 · 2018: 415 · 2017: 343 · 2016: 282 · 2015: 220 · 2014: 163 · 2013: 78 · 2012: 13
- FWCI
- 116.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- SUNY Digital Repository Support (State University of New York System) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000150)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR043727, U01AR051871, T32AR048522)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, SLICC criteria, ACR classification criteria, diagnostic accuracy, sensitivity and specificity, recursive partitioning, lupus nephritis, antinuclear antibodies, anti-dsDNA antibodies
- MeSH terms
- Antibodies, Anti-Idiotypic, Antibodies, Antinuclear, Biopsy, DNA, Humans, International Agencies, Lupus Erythematosus, Systemic, Lupus Nephritis, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
